Raia Drogasil S.A. RADLY
OTC PK
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 250.14M | 254.06M | 236.02M | 233.84M | 237.32M |
| Total Depreciation and Amortization | 381.64M | 366.58M | 355.38M | 335.99M | 306.64M |
| Total Amortization of Deferred Charges | 46.77M | 44.41M | 40.15M | 37.55M | 43.19M |
| Total Other Non-Cash Items | 57.10M | 47.39M | 32.46M | 8.76M | 20.70M |
| Change in Net Operating Assets | -264.76M | -140.04M | -170.13M | -179.37M | -62.68M |
| Cash from Operations | 470.89M | 572.40M | 493.88M | 436.77M | 545.17M |
| Capital Expenditure | -283.66M | -262.79M | -255.67M | -252.52M | -246.51M |
| Sale of Property, Plant, and Equipment | 120.10K | 225.30K | 119.80K | 119.80K | 105.20K |
| Cash Acquisitions | 28.61M | 28.61M | -- | -- | 0.00 |
| Divestitures | 27.52M | -- | -- | -- | -- |
| Other Investing Activities | -8.76M | 11.68M | -5.80M | 231.10K | -17.81M |
| Cash from Investing | -236.17M | -222.28M | -261.35M | -252.17M | -264.21M |
| Total Debt Issued | 600.00M | 600.00M | 1.10B | 1.19B | 628.87M |
| Total Debt Repaid | -1.38B | -1.82B | -1.66B | -1.58B | -1.58B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -11.17M | -11.17M | -10.94M | -5.48M | -73.29M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -112.61M | -112.62M | -118.26M | -118.19M | -94.78M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -221.60M | -347.33M | -226.84M | -187.16M | -276.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.11M | 2.78M | 5.68M | -2.56M | 3.97M |